3952016
Schiff′s Reagent
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.47
UNSPSC Code:
12352106
Form:
solution
form
solution
Quality Level
shelf life
Expiry date on the label
IVD
for in vitro diagnostic use
pH
<2.0
application(s)
hematology
histology
shipped in
wet ice
storage temp.
2-8°C
Application
Intended for use in Sigma Periodic Acid Staining Procedure, 395. Kit is intended for use with blood, bone marrow, tissue touch preparations or routine tissue sections.
Other Notes
Pararosaniline, 1% and sodium metabisulfate, 4%, in hydrochloric acid, 0.25 mol/L
Use Sigma reagent S5133 for staining glycoproteins in polyacrylamide gels.
Still not finding the right product?
Explore all of our products under Schiff’s Reagent
signalword
Danger
hcodes
Hazard Classifications
Carc. 1B - Eye Dam. 1 - Met. Corr. 1
Storage Class
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Rüdiger Braun et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 26(13), 3468-3480 (2020-04-08)
The standard treatment of patients with locally advanced rectal cancer consists of preoperative chemoradiotherapy (CRT) followed by surgery. However, the response of individual tumors to CRT is extremely diverse, presenting a clinical dilemma. This broad variability in treatment response is
Yan-Yan Song et al.
Oncology letters, 8(1), 431-437 (2014-06-25)
Vasculogenic mimicry (VM) formation is important for invasion and metastasis of tumor cells in gastric adenocarcinoma (GAC). The present study aimed to investigate the association between signal transducer and activator of transcription-3 (STAT3), phosphor-STAT3 (p-STAT3), hypoxia-inducible factor-1α (HIF-1α) and VM
Naser Mobarra et al.
International journal of hematology-oncology and stem cell research, 8(4), 20-29 (2015-03-17)
The use of stem cells is considered as an appropriate source in cell therapy and tissue engineering. Differentiation of human induced Pluripotent Stem Cells (hiPSCs) to Hepatocyte-like Cells (HLCs) on mouse embryonic fibroblasts (MEFs) feeders is confronted with several problems